"Quanten-Aktien Deep-Dive mit IonQ, IBM & Co." - neuer Apple-CEO, Marvell & Atai

The episode opens with daily market commentary from host Noah Leidinger. Despite a rising oil price environment tied to Iran tensions causing a broad market dip, chip manufacturer Marvell surged nearly 5% on reports of negotiations with Alphabet over custom AI chips — notable because Google typically works with Broadcom. The episode also covers American Airlines formally rejecting a merger with United Airlines (causing a ~5% drop in its shares), the reported sale of Brown-Forman to French spirits group Pernod Ricard rather than US rival Sazerac, and several pharma deals including Eli Lilly's up to $7 billion acquisition of biotech firm Kelonia, which focuses on in-body reprogramming of immune cells for cancer therapy. The largest deal of the day was Brad Jacobs' QXO announcing the $17 billion acquisition of Top Build, lifting that stock 20%. In Germany, Commerzbank formally rejected UniCredit's takeover bid. On the speculative side, AST Space Mobile fell ~10% after Blue Origin delivered one of its satellites to the wrong orbit, and an unnamed AI data center company (Fermi) dropped 15% after its co-founder and CEO departed. Positive news came for psychedelic medicine stocks including ATAI Life Sciences and Compass Pathways, apparently on favorable regulatory or legislative developments in Europe.

The episode then transitions to a brief mention of Apple's incoming CEO — a 50-year-old hardware executive who, like Tim Cook, is an Apple lifer. The hope expressed is that his product proximity may drive more innovation, though some skepticism exists because he is seen as a 'nice guy' unlikely to shake things up dramatically. The stock did not react as the transition was widely anticipated.

The main segment features returning guest Daniel, an expert on quantum computing, discussing the recent 30–60% surge in quantum stocks following Nvidia's release of AI models designed to improve quantum processors. Daniel argues that last year's crash — triggered by Jensen Huang's comments that useful quantum computers were 20–30 years away — was an overreaction, and that Nvidia's newer, more supportive stance reflects growing pressure on the company to engage with the quantum space rather than dismiss it. He views Nvidia's AI models for quantum processor optimization as a meaningful strategic signal, even if not a technical breakthrough in itself.

Daniel discusses IBM as the clear commercial hardware market leader, praising the company's consistent execution on its public roadmaps and noting that IBM has promised to reach a 'quantum advantage' moment — solving industrially relevant problems faster than classical computers — by 2026, with preliminary real-world demonstrations already achieved in partnerships with companies like HSBC and BASF. He says the shift in narrative from 'five-year story' to 'one-to-three-year story' on error-corrected quantum computing is what is driving stock price jumps.

On IonQ, Daniel acknowledges it as a world-leading hardware company in the trapped-ion segment and views its recent acquisitions — including Oxford Ionix — as strategically sound moves that have meaningfully accelerated its technical roadmap, though he acknowledges its valuation relative to revenue is debatable. He draws a contrast between IBM's conservative, roadmap-loyal approach and IonQ's more aggressive M&A-driven strategy.

Daniel also mentions other players in the space, including Rigetti (superconducting qubits, already public via SPAC), Pascal (preparing for IPO), IQM (Finnish company with strong European presence), and Horizon Quantum (first quantum software company to IPO, doing so in Singapore). He notes that Google's investment in neutral atom company EQAero signals that even superconducting pioneers believe multiple qubit modalities will coexist, and that the industry has not yet reached consensus on which hardware approach will dominate in 10–15 years. He leaves open the possibility of hybrid systems combining multiple qubit types.